A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.

Clinical trial NCT06143423 · TERMINATED

Trial details

NCT number: NCT06143423
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2023-05-24
Primary completion: 2023-07-26
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.